No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Dapagliflozin does not reduce albuminuria in patients with heart failure and type 2 diabetes (DAPPER study)

byWinnie LiuandMinjee Kim

December 1, 2023

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial

Early surgical valve replacement offers survival benefit in asymptomatic, very severe aortic stenosis

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Several exercise modalities improve sleep quality in patients with sleep disorders

RelatedReports

Sleep duration inversely related to childhood type 2 diabetes risk makers

Cardiology

Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial

April 3, 2026

Imaging biomarkers may improve prediction of aortic valve stenosis

Cardiology

Early surgical valve replacement offers survival benefit in asymptomatic, very severe aortic stenosis

April 3, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

Weekly Rewinds

2 Minute Medicine Rewind March 23, 2026

March 23, 2026

#VisualAbstract: Intravenous Levothyroxine Does Not Increase the Number of Heart Transplants in Unstable Brain-Dead Potential Heart Donors

A Begginer's Guide to Understanding Odds Ratios, Confidence Intervals, and P-values

Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial

2 Minute Medicine Rewind December 3, 2023

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result